Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether + lumefantrine for uncomplicated malaria in Somalia
ACTRN12618001224213Phase 4Completed
- Sponsor
- World Health Organization
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artemether and lumefantrine in Malaria and malaria, sponsored by World Health Organization. Primary endpoints: Percent of treatment failures, Adequate clinical and parasitological response and 1 more. Started Dec 2018; status: completed.
02
Drugs
artemetherlumefantrine
03
Conditions
Malariamalaria
Beyond the preview
Go deeper on ACTRN12618001224213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001224213.